NCT03341117View on ClinicalTrials.gov

Acetylsalicylic Acid and Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 2, 2014

Primary Completion Date

December 2, 2015

Study Completion Date

December 2, 2016

Conditions
Diabetes Mellitus, Type 2Antioxidant Enzyme System
Interventions
DRUG

Acetylsalicylic acid

Acetylsalicylic acid 300 mg per capsule

DRUG

Calcined magnesia

Calcined magnesia 300 mg per capsule

All Listed Sponsors
lead

Centro Universitario de Ciencias de la Salud, Mexico

OTHER

NCT03341117 - Acetylsalicylic Acid and Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter